Cargando…

Advances in Liver Transplantation: where are we in the pursuit of transplantation tolerance?

Liver transplantation is the ultimate treatment option for end‐stage liver disease. Breakthroughs in surgical practice and immunosuppression have seen considerable advancements in survival after transplantation. However, the intricate management of immunosuppressive regimens, balancing desired immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safinia, Niloufar, Vaikunthanathan, Trishan, Lechler, Robert Ian, Sanchez‐Fueyo, Alberto, Lombardi, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Highlights
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015994/ https://www.ncbi.nlm.nih.gov/pubmed/34375446 http://dx.doi.org/10.1002/eji.202048875

Ejemplares similares

Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
por: Safinia, Niloufar, et al.
Publicado: (2015)

Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
por: Safinia, Niloufar, et al.
Publicado: (2016)

Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells
por: Safinia, Niloufar, et al.
Publicado: (2018)

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
por: Sánchez‐Fueyo, Alberto, et al.
Publicado: (2020)

Dysregulated anti-oxidant signalling and compromised mitochondrial integrity negatively influence regulatory T cell function and viability in liver disease
por: Vaikunthanathan, Trishan, et al.
Publicado: (2023)

Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation
por: Sagoo, Pervinder, et al.
Publicado: (2012)

Emergent Transcriptomic Technologies and Their Role in the Discovery of Biomarkers of Liver Transplant Tolerance
por: Mastoridis, Sotiris, et al.
Publicado: (2015)

Transplantation tolerance
por: Salisbury, Emma M., et al.
Publicado: (2013)

Immunotherapy after liver transplantation: Where are we now?
por: Au, Kin Pan, et al.
Publicado: (2021)

First stem cell transplantation to regenerate human lung
por: Wang, Si, et al.
Publicado: (2018)

Transplants in Brazil: where are we?
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2019)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

The emerging roles of transplanted radial glial cells in regenerating the central nervous system
por: White, Robin E., et al.
Publicado: (2015)

Biomarkers for renal transplantation: where are we?
por: Ge, Fangmin, et al.
Publicado: (2013)

Fecal microbiota transplantation – where are we?
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018)

Extracellular vesicles as mediators of alloimmunity and their therapeutic potential in liver transplantation
por: Mastoridis, Sotiris, et al.
Publicado: (2020)

We refuse to die – T cells causing havoc
por: Kattner, Aila Akosua
Publicado: (2021)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

A role for complement blockade in kidney transplantation
por: Karpman, Diana, et al.
Publicado: (2022)

HIV and Solid Organ Transplantation: Where Are we Now
por: Botha, Jean, et al.
Publicado: (2019)

Complement Inhibition in Kidney Transplantation: Where Are We Now?
por: Vonbrunn, Eva, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go
por: Lv, Meng, et al.
Publicado: (2012)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?
por: Rebollo‐Mesa, I., et al.
Publicado: (2016)

Up or down: where comes Omicron?
por: Liu, Zezhong, et al.
Publicado: (2022)

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
por: Morè, Sonia, et al.
Publicado: (2022)

Deletional tolerance prevents AQP4‐directed autoimmunity in mice
por: Vogel, Anna‐Lena, et al.
Publicado: (2017)

IL‐2 therapy preferentially expands adoptively transferred donor‐specific Tregs improving skin allograft survival
por: Ratnasothy, Kulachelvy, et al.
Publicado: (2019)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Oh lazy sister, where art thou?
por: Breuer, Manuel
Publicado: (2021)

Clinical Transplantation and Tolerance: Are We There Yet?
por: Saidi, R. F., et al.
Publicado: (2014)

Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021)

Gγ subunit AT1/GS3-the “code” of alkaline tolerance in main graminaceous crops
por: Ju, Chuanfeng, et al.
Publicado: (2023)

ERS International Congress 2020: highlights from the Thoracic Surgery and Transplantation Assembly
por: Esendagli, Dorina, et al.
Publicado: (2021)

Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
por: Derosa, Lisa, et al.
Publicado: (2021)

‘Nur'turing tumor T cell tolerance and exhaustion: novel function for Nuclear Receptor Nur77 in immunity
por: Lith, Sanne C., et al.
Publicado: (2020)

Novel discovery in roles of structural variations and RWP-RK transcription factors in heat tolerance for pearl millet
por: Huang, Bingru, et al.
Publicado: (2023)

Human Stem Cell Transplantation for Retinal Degenerative Diseases: Where Are We Now?
por: Alcalde, Ignacio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4kokojido71tlmcl20ikft32l